Article Information
- May 26, 2020.
Article Versions
- You are currently viewing Version 1 of this article (May 26, 2020 - 08:24).
- View Version 2, the most recent version of this article.
Author Information
- Alyssa Bilinski, MS*,
- Meagan Fitzpatrick, PhD†,
- Scott Sheffield, PhD‡,
- Nicole Swartwood, MSPH§,
- Anne Williamson, MPhil¶ and
- Anna York, PhD‖,**,#
- *Interfaculty Initiative in Health Policy, Harvard Graduate School of Arts and Sciences
- †Center for Vaccine Development and Global Health, University of Maryland School of Medicine
- ‡Department of Mathematics, Massachusetts Institute of Technology
- §Prevention Policy Modeling Lab, Harvard TH Chan School of Public Health
- ¶Barts and the London School of Medicine
- ‖Department of Epidemiology (Microbial Diseases), Yale School of Public Health
- ↵#Corresponding author; email: anna.york{at}yale.edu
↵** Authors are listed in alphabetical order by last name, and author order does not reflect contributions. This work benefited from comments from members of the COVID-19 Statistics, Policy modeling, and Epidemiology Collective, particularly Dr. Joshua Salomon, Samantha Burn, Monica Farid and Dr. Simon Mongey. This is a working paper and remains in development.